UNSPSC 51172824: Eucalyptol/menthol/thymol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR900. This VA Drug Class (OR900) classifies this compound as belonging to the group DENTAL AND ORAL AGENTS, TOPICAL, OTHER.

UNSPSC 51172824 Eucalyptol/menthol/thymol is a Commodity code encompassing over-the-counter topical and ingestible products containing these active ingredients, which state and local governments procure as part of broader generic pharmaceuticals and OTC supplies programs. State and local issuing bodies—primarily cooperative purchasing alliances administering multi-jurisdictional procurement on behalf of member states, counties, and municipalities—buy these products through framework agreements that establish pricing and supply relationships with manufacturers and authorized wholesalers. The solicitation framework typically requires vendors to hold current Good Manufacturing Practices (cGMP) certification, comply with FDA requirements and the Drug Supply Chain Security Act (DSCSA), maintain minimum insurance coverage including $5,000,000 commercial general liability, and distribute through authorized pharmaceutical wholesalers with chargeback systems in place. Products must be available in the marketplace within defined timelines and carry expiration dates of at least one year from manufacture with a six-month minimum shelf life.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026. The solicitation draws manufacturers into a tiered pricing model weighted heavily on price competitiveness (75 percent), supported by compliance with administrative data format requirements, EDI capability, and fixed pricing terms. Awarded vendors must maintain contractual relationships with at least two of three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and accept a 3 percent administrative fee on all contract purchases. The resulting agreements are effective July 1, 2026, for a two-year initial term with optional MMCAP extensions.